Stock Scorer

Avalo Therapeutics, Inc. (AVTX)

12.01USD -9.29% (-1.23)

Over 5Y: -99.8%

Style
Area Line Line with markersshows 1Y Steps Candlesshows 6M Hollow candlesshows 6M Barsshows 6M

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

2 000 4 000 6 000
2022 2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›

Avalo Therapeutics, Inc. reported revenue of 59K USD for the quarter ending 31 December 2025. Every figure, period by period ›

Q3 '21 — Revenue: 1.4M Q3 '21 — Operating Cash Flow: -16.3M Q3 '21 — Free Cash Flow: -16.4M Q3 '21 — Net Income: -17.4M Q4 '21 — Revenue: 219K Q4 '21 — Operating Cash Flow: -17.1M Q4 '21 — Free Cash Flow: -17.1M Q4 '21 — Net Income: -19.2M Q1 '22 — Revenue: 1.2M Q1 '22 — Operating Cash Flow: -16.1M Q1 '22 — Free Cash Flow: -16.1M Q1 '22 — Net Income: -22.1M Q2 '22 — Revenue: 1M Q2 '22 — Operating Cash Flow: -12.5M Q2 '22 — Free Cash Flow: -12.5M Q2 '22 — Net Income: -13M Q3 '22 — Revenue: 14.9M Q3 '22 — Operating Cash Flow: 5.7M Q3 '22 — Free Cash Flow: 5.7M Q3 '22 — Net Income: 3.2M Q4 '22 — Revenue: 896K Q4 '22 — Operating Cash Flow: -3.9M Q4 '22 — Free Cash Flow: -3.9M Q4 '22 — Net Income: -9.8M Q1 '23 — Revenue: 475K Q1 '23 — Operating Cash Flow: -10.1M Q1 '23 — Net Income: -10M Q2 '23 — Revenue: 643K Q2 '23 — Operating Cash Flow: -11M Q2 '23 — Net Income: -8.2M Q3 '23 — Revenue: 236K Q3 '23 — Operating Cash Flow: -6.8M Q3 '23 — Free Cash Flow: -6.8M Q3 '23 — Net Income: -5.2M Q4 '23 — Revenue: 571K Q4 '23 — Operating Cash Flow: -2.8M Q4 '23 — Free Cash Flow: -2.8M Q4 '23 — Net Income: -8.2M Q1 '24 — Revenue: 0 Q1 '24 — Operating Cash Flow: -6.2M Q1 '24 — Net Income: -121.3M Q2 '24 — Revenue: 0 Q2 '24 — Operating Cash Flow: -16.3M Q2 '24 — Net Income: 98.5M Q3 '24 — Revenue: 249K Q3 '24 — Operating Cash Flow: -11.5M Q3 '24 — Net Income: 23M Q4 '24 — Revenue: 192K Q4 '24 — Operating Cash Flow: -15M Q4 '24 — Net Income: -35.3M Q1 '25 — Operating Cash Flow: -9.5M Q1 '25 — Net Income: -13.1M Q2 '25 — Operating Cash Flow: -11.4M Q2 '25 — Net Income: -20.8M Q3 '25 — Revenue: 0 Q3 '25 — Operating Cash Flow: -16.4M Q3 '25 — Net Income: -30.6M Q4 '25 — Revenue: 59K Q4 '25 — Operating Cash Flow: -14.2M Q4 '25 — Net Income: -13.7M Q1 '26 — Operating Cash Flow: -17.7M Q1 '26 — Net Income: -19.6M Q2 '26 — Operating Cash Flow: -20M Q2 '26 — Net Income: -36.4M -100M -50M 0 50M 100M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.8
Accruals -6.5%
Asset turnover 0.00012×
ROA -20.4%
ROCE -19.5%
ROE -22.4%
SG&A / sales 45871.2%
ROIC -149.2%

7 of 19 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

2.8
P/C 1.6×
P/B 1.4×
EV/Sales 3978.0×
FCF yield -10.8%
EV/OE -2.8×

5 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

8.2
Current ratio 19.3×
Debt / Eq 0.0×
Debt payback 0.0 yr
ND/EBITDA 1.7
Quick ratio 19.3×
Cash runway 5.9 yr
F-score 1.3 pts

11 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.2
Sales Q/Q +1066.8%
Sales CAGR 4Y -67.7%
Sales/sh Y/Y -92.5%
Shares change +78.9%

6 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.

Companies of a similar size

The nearest by market value among the companies read here whose shares are quoted in USD. Size alone: nothing here says they are in the same business.

Every listed company from the United States, largest first ›